Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores
-
Envío de manuscritos
Indexed in:
Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME
See moreFollow us:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2022
0.6
Citescore 2022
1.3
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2022
0.163
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2022
0.26
View more metrics
Hide
Journal Information
All issues
Years
- 2024-2021
- 2020-2011
- 2010-2001
- 2000-1991
Select Year
Volume 29 Year 2012
October - December
Vol. 29. Issue 4.Pages 113-162 (October - December 2012)
July - September
Vol. 29. Issue 3.Pages 57-112 (July - September 2012)
April - June
Vol. 29. Issue 2.Pages 29-56 (April - June 2012)
January - March
Vol. 29. Issue 1.Pages 1-28 (January - March 2012)
Publish in
Hipertensión y Riesgo Vascular
Special content about COVID-19
- Type 2 diabetes patients requiring empagliflozin in Southeast of Iran: Frequency and guideline adherence (2022–2023)
- Cefalea e hipertensión como forma de presentación de un feocromocitoma y simulando un síndrome post-COVID-19
- Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration
- Niveles plasmáticos de troponina T y de la fracción aminoterminal del propéptido natriurético cerebral y su relación con mortalidad en COVID-19
Free access articles
Hipertens Riesgo Vasc. 2023;40:75-84
Hipertens Riesgo Vasc. 2022;39:174-94
Hipertens Riesgo Vasc. 2022;39:69-78